Obstetrics & Gynaecology · Hypertensive Disorders in Pregnancy (Pre-eclampsia, Eclampsia)

Magnesium sulphate is the drug of choice for prevention of eclamptic seizures. In a woman receiving MgSO4, which clinical sign indicates early magnesium toxicity that should prompt dose reduction?

  • A Respiratory rate < 16/min
  • B Urinary output < 30 mL/hr
  • C Loss of deep tendon reflexes (DTR)
  • D Serum magnesium > 7.5 mEq/L
Correct answer: C. Loss of deep tendon reflexes (DTR)

Explanation

Magnesium toxicity monitoring: therapeutic range is 4–8 mg/dL (3.5–7 mEq/L); loss of patellar reflex (DTR) occurs at 7–10 mg/dL (6–8 mEq/L) and is the first clinical sign of toxicity that should prompt stopping MgSO4; respiratory paralysis occurs at 10–13 mg/dL; cardiac arrest at > 15 mg/dL. Clinical monitoring (DTR every 30 min, respiratory rate > 12/min, UO > 25–30 mL/hr) is mandatory; patellar reflex loss is the primary safety endpoint.

Reference: Williams Obstetrics, 26th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 23,000+ MCQs.

Start free → Log in

More Hypertensive Disorders in Pregnancy (Pre-eclampsia, Eclampsia) MCQs

See all Hypertensive Disorders in Pregnancy (Pre-eclampsia, Eclampsia) MCQs →